# Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma

> **NCT00752323** · PHASE2 · COMPLETED · sponsor: **Andrew Sloan, MD** · enrollment: 73 (actual)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** aminolevulinic acid
- **PROCEDURE:** Surgical Resection

## Key facts

- **NCT ID:** NCT00752323
- **Lead sponsor:** Andrew Sloan, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12-08
- **Primary completion:** 2018-09-15
- **Final completion:** 2018-10-14
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2021-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00752323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00752323, "Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00752323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*